Minimally Invasive vs. Open Pancreatoduodenectomy: Recovery Insights
Minimally invasive pancreatoduodenectomy (mipd) enhances recovery compared to open pancreatoduodenectomy (opd), especially in the month post-surgery.
Newsletter
General Surgery
Best Papers in General Surgery
The five that matter, every day.
Surgeon Attrition: A Growing Concern for Surgical Care
Surgeon attrition is threatening surgical services, particularly in key specialties.
Muscle Loss Impacts Survival in Advanced Esophageal Cancer
Excessive muscle loss during neoadjuvant therapy significantly predicts survival outcomes in locally advanced esophageal squamous cell carcinoma.
Robotic Pump Placement for Liver Metastasis Key to Minimally Invasive Approach
Minimally invasive robotic placement of hepatic artery infusion pumps shows promise for recurrent colorectal liver metastasis patients post-hemihepatectomy.
Outcomes Similar for Immune Therapy After Nivolumab in Esophageal Cancer
First-line immune checkpoint inhibitor therapy for esophageal cancer recurrence shows no advantage based on prior adjuvant nivolumab treatment.
Whole Blood Prehospital Transfusion Doesn’t Lower Mortality
Using whole blood for prehospital transfusions in trauma patients does not significantly decrease 30-day mortality compared to blood components.
Reducing Postoperative Mortality in Low-Income Countries
Postoperative mortality is a major issue in low- and middle-income countries, and this review identifies key interventions that can help.
Surgical innovation drives precision and personalization in patient care.
Surgeons should prioritize collaboration with engineers and scientists to leverage these advancements effectively.
Multimodal Prehabilitation Cuts Complications in Colorectal Surgery
A national study shows that multimodal prehabilitation significantly reduces complications in colorectal cancer surgery, improving outcomes for patients.
Neoadjuvant Chemo May Not Improve Survival in Early PDAC
Neoadjuvant chemotherapy's benefit in early-stage pancreatic ductal adenocarcinoma is questionable due to bias in survival estimates.